Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity.

Blood
Anna CastletonAdele K Fielding

Abstract

Clinical trials of oncolytic attenuated measles virus (MV) are ongoing, but successful systemic delivery in immune individuals remains a major challenge. We demonstrated high-titer anti-MV antibody in 16 adults with acute lymphoblastic leukemia (ALL) following treatments including numerous immunosuppressive drugs. To resolve this challenge, human bone marrow-derived mesenchymal stromal cells (BM-MSCs) were used to efficiently deliver MV in a systemic xenograft model of precursor B-lineage-ALL. BM-MSCs were successfully loaded with MV ex vivo, and MV was amplified intracellularly, without toxicity. Live cell confocal imaging demonstrated a viral hand-off between BM-MSCs and ALL targets in the presence of antibody. In a murine model of disseminated ALL, successful MV treatment (judged by bioluminescence quantification and survival) was completely abrogated by passive immunization with high-titer human anti-MV antibody. Importantly, no such abrogation was seen in immunized mice receiving MV delivered by BM-MSCs. These data support the use of BM-MSCs as cellular carriers for MV in patients with ALL.

References

Oct 12, 2000·Journal of Virology·U SchneiderR Cattaneo
Jan 9, 2001·Hematology/oncology Clinics of North America·N GökbugetD Messerer
May 2, 2002·Nature Medicine·Kah-Whye PengStephen J Russell
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles LinkerWillis Navarro
Feb 8, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Amanda D BucheitAdele K Fielding
Sep 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xavier ThomasDenis Fiere
Oct 21, 2005·Cytotherapy·E M HorwitzUNKNOWN International Society for Cellular Therapy
Apr 28, 2006·Breast Cancer Research and Treatment·Cari J McDonaldEvanthia Galanis
May 30, 2006·Transplantation·Olle RingdénKatarina Le Blanc
Oct 13, 2006·Blood·Adele K FieldingUNKNOWN Eastern Cooperative Oncology Group
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ianko D IankovStephen J Russell
Jan 30, 2007·Nature Clinical Practice. Oncology·Ta-Chiang LiuDavid Kirn
Mar 24, 2007·The Journal of Clinical Investigation·Shotaro IwamotoDario Campana
Jan 16, 2008·Expert Opinion on Biological Therapy·Cory AllenEvanthia Galanis
May 13, 2008·Lancet·Katarina Le BlancUNKNOWN Developmental Committee of the European Group for Blood and Marrow Transplantation
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura VidalJohann S DeBono
Jun 23, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Partow KebriaeiJoseph Uberti
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil N SenzerJohn J Nemunaitis
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emily K MaderKah-Whye Peng
Mar 18, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chunsheng LiuKah-Whye Peng
May 25, 2010·Neuro-oncology·Adam W StudebakerCorey Raffel
Mar 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bella PatelAdele K Fielding

❮ Previous
Next ❯

Citations

Aug 19, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aditi DeyAdele K Fielding
Mar 2, 2016·Viruses·Gabriella Campadelli-FiumeValentina Gatta
Apr 9, 2016·Oncoimmunology·Jonathan PolLorenzo Galluzzi
Aug 7, 2014·Oncoimmunology·Jonathan PolLorenzo Galluzzi
Mar 1, 2014·Blood·Edwin M Horwitz
May 18, 2016·Advanced Drug Delivery Reviews·Ryosuke KojimaMartin Fussenegger
May 25, 2016·Nature Reviews. Urology·Zahid DelwarWilliam Jia
Oct 27, 2016·Viruses·Sarah ArefAdele Fielding
Jan 29, 2017·Expert Opinion on Biological Therapy·Steven Robinson, Evanthia Galanis
Aug 3, 2018·Stem Cells Translational Medicine·Timothy E G KruegerW Nathaniel Brennen
Aug 11, 2017·Human Gene Therapy·Margaret R DuffyLen W Seymour
Sep 13, 2017·Expert Opinion on Drug Delivery·Gina LiIrina V Balyasnikova
Sep 20, 2019·Journal of Experimental & Clinical Cancer Research : CR·Mao XiaJiwu Wei
Dec 3, 2015·Expert Opinion on Biological Therapy·Elizabeth S AppletonAlan Melcher
Sep 18, 2015·Oncotarget·Virgínea de Araújo FariasJosé Mariano Ruiz de Almodóvar
Sep 28, 2017·Stem Cells International·Nicola Stefano FracchiollaAgostino Cortelezzi
Aug 1, 2018·International Journal of Molecular Sciences·Kamal Shaik FakiruddinSyahril Abdullah
Feb 10, 2021·Journal for Immunotherapy of Cancer·Rafael Moreno
Feb 5, 2021·Cancers·Christine E Engeland, Guy Ungerechts
Feb 12, 2020·European Journal of Pharmacology·Agata HadryśJoanna Jazowiecka-Rakus
Aug 11, 2020·Molecular Therapy Oncolytics·Joanna Jazowiecka-RakusGrant McFadden
Apr 25, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chen YangXiangmin Tong
Jun 18, 2021·Stem Cell Reviews and Reports·Alison R Mercer-SmithShawn D Hingtgen
Jul 30, 2021·Frontiers in Cell and Developmental Biology·Ali HassanzadehMostafa Jarahian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.